Home/MygoGenesis/Marc Solomon
MS

Marc Solomon

Chief Financial Officer

MygoGenesis

MygoGenesis Pipeline

DrugIndicationPhase
Mygotic Platform TherapeuticsCardiac/Neural/Pancreatic tissue repair, Cancer vaccinesPre-clinical
HematoGenesis™Production of Type O Negative bloodResearch
MyCellSafe™Autologous cell banking for future medical useDevelopment
AmeboGenesis™Sustainable production of amebocytes for LAL endotoxin testingDevelopment